Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIGHT: Levothyroxine for Isolated Gestational Hypothyroidism in Recurrent Pregnancy Loss
NCT06999278Phase 3Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Jun 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Hypothyroxinemia comparing Levothyroxine with Placebo (2 arms). Primary endpoint: Live birth after 28 weeks of gestation. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
Hypothyroxinemia
Beyond the preview
Go deeper on NCT06999278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999278.